MLAB Insider Trading

Insider Ownership Percentage: 4.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,075,580.16

Mesa Laboratories Insider Trading History Chart

This chart shows the insider buying and selling history at Mesa Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M-$1M$0$1M$2MTotal Insider BuyingTotal Insider Selling

Mesa Laboratories Share Price & Price History

Current Price: $108.00
Price Change: Price Decrease of -0.39 (-0.36%)
As of 04/4/2025 05:00 PM ET

This chart shows the closing price history over time for MLAB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$108.00Closing price on 04/05/25:

SEC Filings (Institutional Ownership Changes) for Mesa Laboratories (NASDAQ:MLAB)

90.60% of Mesa Laboratories stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MLAB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$282ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$400M-$200M$0$200M$400MTotal InflowsTotal Outflows
Mesa Laboratories logo
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Read More on Mesa Laboratories

Today's Range

Now: $108.00
Low: $97.20
High: $110.37

50 Day Range

MA: $134.01
Low: $108.00
High: $154.76

52 Week Range

Now: $108.00
Low: $83.68
High: $155.12

Volume

60,296 shs

Average Volume

38,510 shs

Market Capitalization

$586.87 million

P/E Ratio

N/A

Dividend Yield

0.54%

Beta

0.82

Who are the company insiders with the largest holdings of Mesa Laboratories?

Mesa Laboratories' top insider shareholders include:
  1. John Bradley Schmieder (Director)
  2. Gary M Owens (CEO)
  3. Brian David Archbold (SVP)
Learn More about top insider investors at Mesa Laboratories.

Who are the major institutional investors of Mesa Laboratories?

Mesa Laboratories' top institutional shareholders include:
  1. Kings Path Partners LLC — 0.08%
Learn More about top institutional investors of Mesa Laboratories stock.

Which major investors are selling Mesa Laboratories stock?

In the previous quarter, MLAB stock was sold by these institutional investors:
  1. Kings Path Partners LLC
In the previous year, company insiders that have sold Mesa Laboratories company stock include:
  1. John Bradley Schmieder (Director)
  2. Gary M Owens (CEO)
Learn More investors selling Mesa Laboratories stock.